Microvascular Permeability in Diabetes and Insulin Resistance

REFERENCES

• Aiello L P. The potential role of PKC β in diabetic retinopathy and macular edema. Surv of Ophthalmol 2002; 47: S263–S269
   Google Scholar
• Andersen S K, Gjedsted J, Christiansen C, Tonnesen E. The roles of insulin and hyperglycemia in sepsis pathogenesis. J Leukoc Biol 2004; 75: 413–421
   Google Scholar
• Antonetti D A, Lieth E, Barber A J, Gardner T W. Molecular mechanisms of vascular permeability in diabetic retinopathy. Sem Ophthalmol 1999; 14: 240–248
   PubMedGoogle Scholar
• Aramoto H, Breslin J W, Pappas P J, Hobson R W, 2nd, Duran W N. Vascular endothelial growth factor stimulates differential signaling pathways in in vivo microcirculation. Am J Physiol Heart Circ Physiol 2004; 287: H1590–H1598
   PubMed Web of Science ®Google Scholar
• Baron A D. The coupling of glucose metabolism and perfusion in human skeletal muscle. Diabetes 1996; 45: S105–S109, suppl
   Google Scholar
• Bates D O, Harper S J. Regulation of vascular permeability by vascular endothelial growth factors. Vascul Pharmacol 2003; 39: 225–237
   Web of Science ®Google Scholar
• Beals C C, Bullock J, Jáuregui E R, Durán W N. Microvascular clearance of macromolecules in skeletal muscle of spontaneously diabetic rats. Microvas Res 1993; 45: 11–19
   Google Scholar
• Bochicchio G V, Sung J, Joshi M, Bochicchio K, Johnson S B, Meyer W, Scalea T M. Persistent hyperglycemia is predictive of outcome in critically ill trauma patients. J Trauma 2005; 58: 921–924
   PubMedGoogle Scholar
• Bohlen H G. Mechanisms for early microvascular injury in obesity and type II diabetes. Curr Hypertens Rep 2004; 6: 60–65
   PubMedGoogle Scholar
• Bonnardel-Phu E, Wautier J, Schmidt A M, Avila C, Vicaut E. Acute modulation of albumin microvascular leakage by advanced glycation end products in microcirculation of diabetic rats in vivo. Diabetes 1999; 48: 2052–2058
   PubMed Web of Science ®Google Scholar
• Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes 2005; 54: 1615–1625
   PubMed Web of Science ®Google Scholar
• Caldwell R B, Bartoli M, Behzadian M A, el-Remessy A EB, Al-Shabrawey M, Platt D H, Liou G I, Caldwell R W. Vascular endothelial growth factor and diabetic retinophathy: role of oxidative stress. Curr Drug Targets 2005; 6: 511–524
   PubMed Web of Science ®Google Scholar
• Chehade J M, Haas M J, Mooradian A D. Diabetes-related changes in rat cerebral occluding and zonula occludens-1 (ZO-1) expression. Neurochem Res 2002; 27: 249–252
   PubMed Web of Science ®Google Scholar
• Clark M G, Barrett E J, Wallis M G, Vincent M A, Rattigan S. The microvasculature in insulin resistance and type 2 diabetes. Sem Vascul Med 2002; 2: 21–31
   Google Scholar
• Clerk L H, Rattigan S, Clark M G. Lipid infusion impairs physiologic insulin-mediated capillary recruitment and muscle glucose uptake in vivo. Diabetes 2002; 51: 1138–45
   PubMed Web of Science ®Google Scholar
• Coggins M, Lindner J, Rattigan S, Jahn L, Fasy E, Kaul S, Barrett E. Physiologic hyperinsulinemia enhances human skeletal muscle perfusion by capillary recruitment. Diabetes 2001; 50: 2682–2690
   PubMed Web of Science ®Google Scholar
• Colantuoni A, Lapi D, Paterni M, Marchiafava P L. Protective effects of insulin during ischemia–reperfusion injury in hamster cheek pouch microcirculation. J Vasc Res 2005; 42: 55–66
   Google Scholar
• Curtis T M, Scholfield C N. The role of lipids and protein kinase Cs in the pathogenesis of diabetic retinophathy. Diabetes Metab Res Rev 2004; 20: 28–43
   PubMed Web of Science ®Google Scholar
• Curry F E, Adamson R H. Transendothelial pathways in venular microvessels exposed to agents which increase permeability: the gaps in our knowledge. Microcirculation 1999; 6: 3–5
   Google Scholar
• Davidson M K, Patricia K R, Glick G G, Hoffman L H, Chang M S, Haselton F R. Reduced expression of the adherens junction protein cadherin-5 in a diabetic retina. Am J Ophthalmol 2000; 129: 267–296
   Google Scholar
• Dell'Omo G, Penno G, Pucci L, Mariani M, Prato S D, Pedrinelli R. Abnormal capillary permeability and endothelial dysfunction in hypertension with comorbid metabolic syndrome. Atherosclerosis 2004; 172: 383–389
   PubMedGoogle Scholar
• Esposito C, Gerlach H, Brett J, Stern D, Vlassara H. Endothelial receptor-mediated binding of glucose-modified albumin is associated with increased monolayer permeability and modulation of cell surface coagulant properties. J Exp Med 1989; 170: 1387–1407
   PubMed Web of Science ®Google Scholar
• Farese R V. Insulin-sensitive phospholipids signaling systems and glucose transport: update II. Exp Biol Med 2001; 226: 283–295
   PubMed Web of Science ®Google Scholar
• Ferro T, Neumann P, Gertzberg N, Clements R, Johnson A. Protein kinase C-α mediates endothelial barrier dysfunction induced by TNF-α. Am J Physiol Lung Cell Mol Phyisol 2000; 278: L1107–L1117
   Web of Science ®Google Scholar
• Frisbee J C. Reduced nitric oxide bioavailability contributes to skeletal muscle microvessel rarefaction in the metabolic syndrome. Am J Physiol Regul Integr Comp Physiol 2005; 289: R307–R316
   Google Scholar
• Gearhart M M, Parbhoo S K. Hyperglycemia in the critically ill patient. AACN Clin Issues 2006; 1: 50–55
   Google Scholar
• Gaudreault N, Santure M, Pitre M, Nadeau A, Marette A, Bachelard H. Effect of insulin on regional blood flow and glucose uptake in Wistar and Sprague Dawley rats. Metabolism 2001; 50: 65–73
   Google Scholar
• Goldin A, Beckman J A, Schmidt A M, Creager M A. Advanced glycation end products: sparking the development of diabetic vascular injury. Circulation 2006; 114: 597–605
   PubMed Web of Science ®Google Scholar
• Goodfellow J. Microvascular heart disease in diabetes mellitus. Diabetologia 1997; 40: S130–S133
   Google Scholar
• Gudbjornsdottir S, Sjostrand M, Strindberg L, Lonnroth P. Decreased muscle capillary permeability surface area in type 2 diabetic subjects. J Clin Endocrinol Metab 2005; 90: 1078–1082
   Google Scholar
• Guo M, Wu M H, Korompai F, Yuan S Y. Upregulation of PKC genes and isozymes in cardiovascular tissues during early stages of experimental diabetes. Physiol Genomics 2003; 12: 139–146
   Google Scholar
• Harrington E O, Brunelle J L, Shannon C J, Kim E S, Mennella K, Rounds S. Role of protein kinase C isoforms in rat epididymal microvascular endothelial barrier function. Am J Respir Cell Mol Biol 2003; 28: 626–636
   Google Scholar
• Haselton F R, Dworska E J, Hoffman L H. Glucose-induced increase in paracellular permeability and disruption of beta-receptor signaling in retinal endothelium. Invest Ophthalmol Vis Sci 1998; 39: 1676–84, 1998
   Google Scholar
• He Z, King G L. Microvascular complications of diabetes. Endocrinol Metab Clin N Am 2004; 33: 215–238
   PubMed Web of Science ®Google Scholar
• Hempel A, Maasch C, Heintze U, Lindschau C, Dietz R, Luft F C, Haller H. High glucose concentrations increase endothelial cell permeability via activation of protein kinase C alpha. Circ Res 1997; 81: 363–371
   Google Scholar
• Hilsted J, Christensen N J. Dual effect of insulin on plasma volume and transcapillary albumin transport. Diabetologia 1992; 35: 99–103
   Google Scholar
• Huber J D, Van Gilder R L, Houser K A. Streptozotocin-induced diabetes progressively increases blood–brain barrier permeability in specific brain regions in rats. Am J Phyisol Heart Circ Phyisol 2006; 291: H2660–H2668
   Google Scholar
• Idris I, Gray S, Donnelly R. Protein kinase C activation: isozyme-specific effects on metabolism and cardiovascular complications in diabetes. Diabetologia 2001; 44: 659–673
   PubMed Web of Science ®Google Scholar
• Idris I, Gray S, Donnelly R. Rosiglitazone and pulmonary oedema: an acute dose-dependent effect on human endothelial cell permeability. Diabetologia 2003; 46: 288–290
   PubMed Web of Science ®Google Scholar
• Jeschke M G, Klein D, Herndon D N. Insulin treatment improves the systemic inflammatory reaction to severe trauma. Ann Surg 2004; 239: 553–560
   PubMed Web of Science ®Google Scholar
• Joy S V, Scates A C, Bearelly S, Dar M, Taulien C A, Goebel J A, Cooney M J. Ruboxistaurin, a protein kinase C β inhibitor, as an emerging treatment for diabetes microvascular complications. Ann Pharmacother 2005; 39: 1693–1699
   PubMed Web of Science ®Google Scholar
• Kalambokis G N, Tsatsoulis A A, Tsianos E V. The edematogenic properties of insulin. Am J Kidney Dis 2004; 44: 575–590
   PubMed Web of Science ®Google Scholar
• Kang N, Alexander G, Park J K, Maasch C, Buchwalow I, Luft F C, Haller H. Differential expression of protein kinase C isoforms in streptozotocin-induced diabetic rats. Kidney Int 1999; 6: 1737–1750
   Google Scholar
• Kornerup K, Nordestgaard B G, Feldt-Rasmussen B, Borch-Johnses K, Jensen K S, Jensen J S. Transvascular low-density lipoprotein transport in patients with diabetes mellitus (type 2): a noninvasive in vivo isotope technique. Arterioscler Thromb Vasc Biol 2002; 22: 1168–1174
   Google Scholar
• Koya D, King G L. Protein kinase C activation and the development of diabetic complications. Diabetes 1998; 47: 859–866
   PubMed Web of Science ®Google Scholar
• Laakso M, Edelman S, Brechtel G, Baron A D. Decreased effects of insulin to stimulate skeletal muscle blood flow in obese man. J Clin Invest 1990; 85: 1844–1852
   PubMed Web of Science ®Google Scholar
• Laird A M, Miller P R, Kilgo P D, Meredith J W, Chang M C. Relationship of early hyperglycemia to mortality in trauma patients. J Trauma 2004; 56: 1058–1062
   PubMedGoogle Scholar
• Langouche L, Vanhorebeek I, Vlasselaers D, Perre S V, Wouters P J, Skogstrand K, Hansen T K, Van den Berghe G. Intensive insulin therapy protects the endothelium of critically ill patients. J Clin Invest 2005; 115: 2277–2286
   PubMed Web of Science ®Google Scholar
• Liu X, Wang J, Takeda N, Binaglia L, Pangia V, Dhalla N S. Changes in cardiac protein kinase C activities and isozymes in streptozotocin-induced diabetes. Am J Physiol 1999; 277: E798–E804
   Google Scholar
• McDonagh P F, Hokama J Y. Microvascular perfusion and transport in the diabetic heart. Microcirculation 2000; 7: 163–181
   Google Scholar
• Moore T C, Moore J, Kaji Y, Frizzell N, Usui T, Poulaki V, Cambell I L, Stitt A W, Gardiner T A, Archer D B, Adamis A P. The role of advanced glycation end products in retinal microvascular leukostasis. Invest Ophthalmol Vis Sci 2003; 44: 4457–4464
   PubMed Web of Science ®Google Scholar
• Newton A C. Protein kinase C: structural and spatial regulation by phosphorylation, cofactors, and macromolecular interactions. Chem Rev 2001; 101: 2353–2364
   PubMed Web of Science ®Google Scholar
• Nobe K, Miyatake M, Sone T, Honda K. High-glucose-altered endothelial cell function involves both disruption of cell-to-cell connection and enhancement of force development. J Pharmacol Exp Ther 2006; 318: 530–539
   Google Scholar
• Oomen P HN, Kant G D, Dullaart R PF, Reitsma W D, Smit A J. Acute hyperglycemia and hyperinsulinemia enhance vasodilation in type 1 diabetes mellitus without increasing capillary permeability and inducing endothelial dysfunction. Microvascular 2002; 63: 1–9
   Google Scholar
• Otero K, Martinez F, Beltran A, Gonzalez D, Herrera B, Quintero G, Delgado R, Rojas A. Albumin-derived advanced glycation end-products trigger the disruption of the vascular endothelial cadherin complex in cultured human and murine endothelial cells. Biochem J 2001; 359: 567–574
   PubMed Web of Science ®Google Scholar
• Plante G E, Perreault M, Lanthier A, Marette A, Maheux P. Reduction of endothelial NOS and bradykinin-induced extravasation of macromolecules in skeletal muscle of the fructose-fed rat model. Cardiovasc Res 2003; 59: 963–970
   Google Scholar
• Rask-Madsen C, King G L. Proatherosclerotic mechanisms involving protein kinase C in diabetes and insulin resistance. Arterioscler Thromb Vasc Biol 2004; 25: 487–496
   Google Scholar
• Rath S, Kalogeris T, Mai N, Zibari G, Alexander J S, Lefer D, Turnage R H. Insulin prevents oxidant-induced endothelial cell barrier dysfunction via nitric oxide-dependent pathway. Surgery 2006; 139: 82–91
   Google Scholar
• Rennings A J, Smits P, Stewart M W, Tack C J. Fluid retention and vascular effects of rosiglitazone in obese, insulin-resistant nondiabetic subjects. Diabetes Care 2006; 29: 581–587
   PubMed Web of Science ®Google Scholar
• Salameh A, Zinn M, Dhein S. High d-glucose induces alterations of endothelial cell structure in a cell-culture model. J Cardiovascul Pharmacol 1997; 30: 182–190
   Google Scholar
• Sampathkumar R, Balasubramanyam M, Rema M, Premanand C, Mohan V. A novel advanced glycation index and its association with diabetes and microangiopathy. Metabolism 2005; 54: 1002–1007
   PubMed Web of Science ®Google Scholar
• Sanchez F A, Savalia N B, Duran R G, Lal B K, Boric M P, Duran W N. Functional significance of differential eNOS translocation. Am J Physiol Heart Circ Physiol 2006; 291: H1058–H1064
   PubMed Web of Science ®Google Scholar
• Sasaki R, Whitt S P, Huxley V H. Permeability response of the rat mesenteric microvasculature to insulin. Clin Hemorheol Microcirc 2006; 34: 259–263
   Google Scholar
• Schmidt A M, Yan S D, Yan S F, Stern D M. The biology of the receptor for advanced glycation end products and its ligands. Biochim Biophys Acta 2000; 1498: 99–111
   PubMed Web of Science ®Google Scholar
• Scott J A, King G L. Oxidative stress and antioxidant treatment in diabetes. Ann NY Acad Sci 2004; 1031: 204–213
   PubMed Web of Science ®Google Scholar
• Shore A C. The microvasculature in type 1 diabetes. Sem Vasc Med 2002; 2: 9–20
   PubMedGoogle Scholar
• Sotiropoulos K B, Clermont A, Yasuda Y, Rask-Madsen C, Mastumoto M, Takahashi J, Vecchia K D, Kondo T, Aiello L P, King G L. Adipose-specific effect of rosiglitazone on vascular permeability and protein kinase C activation: novel mechanism for PPARγ agonist's effects on edema and weight gain. FASEB 2006; 20: E367–E380
   Google Scholar
• St-Pierre P, Bouffard L, Papirakis M-E, Maheux P. Increased extravasation of macromolecules in skeletal muscles of the Zucker rat model. Obesity 2006; 5: 787–793
   Google Scholar
• St-Pierre P, Bouffard L, Maheux P. Rosiglitazone increases extravasation of macromolecules and endothelial nitric oxide synthase in skeletal muscles of the fructose-fed rat model. Biochem Pharm 2004; 67: 1997–2004
   PubMed Web of Science ®Google Scholar
• Stenina O I. Regulation of vascular genes by glucose. Curr Pharm Des 2005; 11: 2367–2381
   PubMed Web of Science ®Google Scholar
• Stepp D W. Impact of obesity and insulin resistance on vasomotor tone: nitric oxide and beyond. Clin Exp Pharm Phys 2006; 33: 407–414
   Google Scholar
• Stokes K Y, Cooper D, Tailor A, Granger D N. Hypercholesterolemia promotes inflammation and microvascular dysfunction: role of nitric oxide and superoxide. Free Radic Biol Med 2002; 33: 1026–1036
   PubMed Web of Science ®Google Scholar
• Sun H, Breslin J, Zhu J, Yuan S Y, Wu M H. Rho GTPase in VEGF-induced microvasular hyperpermeability. Microcirculation 2006; 13: 1–11
   Google Scholar
• Tilton R G. Diabetic vascular dysfunction: links to glucose-induced reductive stress and VEGF. Microscopy Res Tech 2002; 57: 390–407
   PubMed Web of Science ®Google Scholar
• Tinsley J H, Teasdale N R, Yuan S Y. Involvement of PKC-delta and PKD in pulmonary microvascular endothelial cell hyperpermeability (2004). Am J Physiol Cell Physiol 2004; 286: C105–C111
   PubMedGoogle Scholar
• Tomlinson D R. Mitogen-activated protein kinases as glucose transducers for diabetic complications. Diabetologia 1999; 42: 1271–1281
   PubMed Web of Science ®Google Scholar
• Tooke J E. Microvascular function in human diabetes. Diabetes 1995; 44: 721–726
   PubMed Web of Science ®Google Scholar
• Tuttle K R, Bakris G L, Toto R D, McGill J B, Hu K, Anderson P W. The effect of ruboxistaurin on nephropathy in type 2 diabetes. Diabetes Care 2005; 28: 2686–2690
   PubMed Web of Science ®Google Scholar
• Valensi P, Cohen-Boulakia F, Attali J R, Behar A. Changes in capillary permeability in diabetic patients. Clin Hermorheol Microcirc 1997; 17: 389–394
   Google Scholar
• Van d en, Berhe G. How does blood glucose control with insulin save lives in intensive care. J Clin Invest 2004; 114: 1187–1195
   Google Scholar
• Van d en, Berghe G, Wilmer A, Hermans G, Meersseman W, Wouters P, Milants I, Wijngaerden E V, Bobbaers H, Bouillon R. Intensive insulin therapy in the medical ICU. N Engl J Med 2006; 254: 449–461
   Google Scholar
• Viberti G. Thiazolidinediones—benefits on microvascular complications of type 2 diabetes. J Diabetes Complications 2004; 19: 168–177
   Google Scholar
• Vincent M A, Montagnani M, Quon M J. Molecular and physiologic actions of insulin related to production of nitric oxide in vascular endothelium. Curr Diab Rep 2003; 3: 279–288
   PubMedGoogle Scholar
• Vink G, Dulling B. Capillary endothelial surface layer selectively reduces plasma solute distribution volume. Am J Phyisol Heart Circ Phyisol 2000; 278: H285–H289
   PubMed Web of Science ®Google Scholar
• Vinores S A, Derevjankik N L, Mahlow J, Berkowitz B A, Wilson C A. Electron microscopic evidence for the mechanism of blood–retinal barrier breakdown in diabetic rabbits: comparison with magnetic resonance imaging. Pathol Res Pract 1998; 194: 497–505
   PubMedGoogle Scholar
• Ward B J, al-Haboubi H A. Structural changes in the cardiac microvasculature of the rat in response to acute high glucose levels: a comparison with diabetes. Microcirculation 1997; 4: 429–437
   Web of Science ®Google Scholar
• Wautier J L, Zoukourian C, Chappey O, Wautier M P, Guillausseau P J, Cao R, Hori O, Stern D, Schmidt A M. Soluble receptor for advanced glycation end products blocks hyperpermeability in diabetic rats. J Clin Invest 1996; 97: 238–243
   PubMed Web of Science ®Google Scholar
• Wolf B A, Williamson J R, Easom R A, Chang K, Sherman W R, Turk J. Diacylglycerol accumulation and microvascular abnormalities induced by elevated glucose levels. J Clin Invest 1991; 87: 31–38
   PubMed Web of Science ®Google Scholar
• Wu H, Huang Q, Yuan Y, Granger H J. VEGF induces NO-dependent hyperpermeability in coronary venules. Am J Physiol 1996; 271: H2735
   PubMed Web of Science ®Google Scholar
• Wu M H, Yuan S Y, Zawieja D C, Tinsley J H, Granger H J. Role of phospholipase C, protein kinase C and calcium in VEGF-induced venular hyperpermeability. Am J Physiol 1999; 276: H535–H542
   Google Scholar
• Wu M H, Yuan S Y, Granger H J. The protein kinase MEK1/2 mediate VEGF- and histamine-induced hyperpermeability in porcine coronary venules. J Physiol (London) 2005; 563: 95–104
   Google Scholar
• Wu M H. Endothelial focal adhesion and barrier function. J Physiol (London) 2005; 569: 359–366
   Google Scholar
• Yamaji T, Fukuhara T, Kinoshita M. Increased capillary permeability to ablumin in diabetic rat myocardium. Circ Res 1993; 72: 947–957
   Google Scholar
• Yendamuri S, Fulda G J, Tinkoff G H. Admission hyperglycemia as a prognostic indicator in trauma. J Trauma 2003; 55: 33–38
   PubMedGoogle Scholar
• Yu P K, Yu D Y, Cringle S J, Su E N. Endothelial F-actin cytoskeleton in the retinal vasculature of normal and diabetic rats. Curr Eye Res 2005; 30: 279–290
   PubMed Web of Science ®Google Scholar
• Yuan S Y, Ustinova E E, Wu H M, Tinsley J H, Korompai F L, Xu W, Taulman A C. PKC activation contributes to microvascular barrier dysfunction in the heart at early stages of diabetes. Circ Res 2000; 87: 412–417
   Google Scholar
• Yuan S Y. Signal transduction pathways in enhanced microvascular permeability. Microcirculation 2000; 7: 395–403
   PubMedGoogle Scholar
• Yuan S Y. Protein kinase signaling in the modulation of microvascular permeability. Vasc Pharmacol 2003; 39: 213–223
   Google Scholar
• Yuan S Y. New insights into eNOS signaling in microvascular permeability. Am J Physiol Heart Circ Physiol 2006; 291: H1029–H1031
   Google Scholar